Moreover, we present evidence that TREM2 prevented HCC metastasis by directly targeting the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/AKT serine/threonine kinase (Akt)/β-catenin pathway. Here, TREM2 is linked to hepatocellular carcinoma.